Alternative messenger RNA splicing is the main reason that vast mammalian proteomic complexity can be achieved with a limited number of genes. Splicing is physically and functionally coupled to transcription, and is greatly affected by the rate of transcript elongation [1] [2] [3] . As the nascent pre-mRNA emerges from transcribing RNA polymerase II (RNAPII), it is assembled into a messenger ribonucleoprotein (mRNP) particle; this is the functional form of the nascent pre-mRNA and determines the fate of the mature transcript 4 . However, factors that connect the transcribing polymerase with the mRNP particle and help to integrate transcript elongation with mRNA splicing remain unclear. Here we characterize the human interactome of chromatin-associated mRNP particles. This led us to identify deleted in breast cancer 1 (DBC1) and ZNF326 (which we call ZNF-protein interacting with nuclear mRNPs and DBC1 (ZIRD)) as subunits of a novel protein complex-named DBIRD-that binds directly to RNAPII. DBIRD regulates alternative splicing of a large set of exons embedded in (A 1 T)-rich DNA, and is present at the affected exons. RNAinterference-mediated DBIRD depletion results in region-specific decreases in transcript elongation, particularly across areas encompassing affected exons. Together, these data indicate that the DBIRD complex acts at the interface between mRNP particles and RNAPII, integrating transcript elongation with the regulation of alternative splicing.
GIGA-R, University of Liege, CHU, Sart-Tilman, 4000 Liege, Belgium. 3 processing and termination factors. Co-immunoprecipitation experiments confirmed the RNA-dependent interaction of some of these proteins with hnRNP A1-Flag ( Supplementary Fig. 2b ). We next focused on two proteins that had not previously been connected to mRNP particles or mRNA processing. One of these, DBC1, is best known for its association with, and regulation of, the sirtuin-like deacetylase SIRT1 (refs 8, 9) . We also investigated the uncharacterized zinc-finger-containing protein ZNF326. Stable cell lines expressing near-normal levels of Flag-tagged versions of these proteins were established, and co-immunoprecipitation experiments confirmed that both DBC1 and ZNF326 interact with mRNP particles in an RNA-dependent manner ( Supplementary Fig. 3a-f) . Furthermore, we discovered that ZNF326 and DBC1 associate directly, in an RNAindependent manner (Fig. 2a, e) . For this reason, hereafter we refer to ZNF326 as ZNF-protein interacting with nuclear mRNPs and DBC1 (ZIRD).
We previously identified DBC1 as an RNAPII-interacting protein in another proteomic screen 10 , making it a particularly interesting candidate. Co-immunoprecipitation experiments confirmed that RNAPII associates with DBC1-Flag in an RNA-independent manner (Fig. 2b) . Furthermore, ZIRD was detected in RNAPII (RPB3-Flag) purifications, and this interaction was also RNA-independent (Fig. 2c) . In further support of a ZIRD-RNAPII interaction, ZIRD-Flag also coimmunoprecipitated RNAPII (Fig. 2d) . In contrast, we failed to detect an interaction between hnRNP A1 and RNAPII under the same conditions (Fig. 2c , middle panel, and data not shown), although coimmunoprecipitation experiments after formaldehyde crosslinking indicated that, as expected, the proteins are in close proximity in vivo ( Supplementary Fig. 4 ). Together, these results indicate that DBC1 and ZIRD are not part of the core mRNP particle, but that they might work at the interface between the mRNP particle and RNAPII.
Others reported that DBC1 interacts with SIRT1 (refs 8, 9 ). Although we observed that DBC1 co-precipitated SIRT1, endogenous ZIRD and ZIRD-Flag did not (Fig. 2e , and data not shown). SIRT1 is also absent from hnRNP-A1-containing mRNP particles (Supplementary Fig. 3g ). This indicates that ZIRD and DBC1 form a complex that lacks SIRT1. To characterize the ZIRD-DBC1 interaction further, ZIRD-Flag was purified. Size-exclusion chromatography of highly purified material showed that ZIRD-Flag and DBC1 are part of a salt-stable ,800-kDa complex (Fig. 2f ) that also co-purified on MonoQ (data not shown). As expected, SIRT1 is not part of this protein complex (Fig. 2g , and data not shown). We named it the DBC1-ZIRD complex (DBIRD).
DBC1 and ZIRD interact with RNAPII in crude extracts ( Fig. 2b-d ). To investigate whether this interaction is direct, the DBIRD complex was characterized by gel filtration after mixing with an excess of RNAPII. In the absence of RNAPII, the DBIRD complex peaked in fractions [13] [14] [15] (Fig. 2f, upper two panels) . However, when mixed with RNAPII (Fig. 2f , lower three panels), DBIRD complex elution shifted to earlier fractions, peaking in fraction 10 with a sub-fraction of RNAPII, whereas polymerase alone peaked in fractions [17] [18] [19] (,500 kDa), as expected. The DBIRD complex thus seems to form a bridging complex that interacts with both mRNP particles and RNAPII. Interestingly, DBIRD also interacted with mRNP particles lacking hnRNP A1 (Fig. 2h ), pointing to a general bridging role.
To examine the role of the DBIRD complex in transcriptionassociated processes in vivo, we analysed the transcriptome of cells that had been depleted for DBC1 or ZIRD by RNA interference (RNAi) (Supplementary Fig. 5a ). Total mRNA was hybridized to GeneChip Human Exon 1.0 ST arrays, on which the abundance of individual exons can be analysed independently. In the absence of ZIRD, a greater than 1.5-fold increase in exon inclusion was observed 
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in more than 2,800 situations, whereas exon exclusion was observed in only 390 cases (Supplementary Table 1a ). The absence of DBC1 led to increased inclusion of an exon in 796 cases (Supplementary Table 1b) and, notably, most of these events were also on the list of ZIRDdependent exon inclusions (567 out of 796 (71%); P-value for shared exons 5 6.705 3 10
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; Supplementary Table 1c) , which strongly supports a close functional relationship between the two factors and provides confidence in the genome-wide alternative splicing data sets. The effect was at the level of alternative splicing, as depletion of ZIRD or DBC1 only affected the expression of a very small number of genes ( Supplementary Fig. 6 ).
A full list of inclusion events observed in both DBC1-and ZIRDdepleted cells is in Supplementary Table 1c . Sample results were confirmed by quantitative PCR with reverse transcription (RT-PCR) ( Supplementary Fig. 7 ). To investigate whether DBIRD was present at affected exons, we performed RNA immunoprecipitation experiments 11 . DBC1 and ZIRD bound the relevant exon in mRNAs from seven tested genes, whereas other regions (or control transfer RNA) were not detected or detected to a much lower extent (Fig. 3a, b and Supplementary Fig. 8 ). Interestingly, some exons of the b-actin gene (whose splicing was unaffected by DBIRD depletion) had considerable levels of DBIRD complex as well ( Supplementary Fig. 8 ), indicating that the interaction of DBIRD with mRNA is not invariably correlated with DBIRD-dependent splicing changes.
To investigate the mechanism underlying exon inclusion, we first searched for sequence motifs in the DNA encompassing the included exons, but failed to uncover motifs other than those known to typify splice junctions. We then looked for nucleotide patterns that might be over-represented in the sequences surrounding the included exons by counting how often each of the 1,024 possible 5-base oligonucleotides occurred. Interestingly, (A 1 T)-rich 5-base oligonucleotides were markedly enriched around included exons (Fig. 3c) . The frequencies of the four nucleotides in the regions around the splice sites were also analysed. A and T were strongly over-represented around the splice sites of DBIRD-affected exons, as well as across the exons themselves (Fig. 3d ). The observed difference in A 1 T content is sufficient to explain the over-representation of (A 1 T)-rich 5-base oligonucleotides ( Supplementary Fig. 9 ).
The (A 1 T)-rich DNA surrounding the affected exons might influence fundamental aspects of transcription. Indeed, A-and T-tracts are difficult for RNAPII to transcribe, as they constitute very efficient elongation pause sites in vitro 12, 13 . To investigate the effect of DBIRD on transcript elongation, we performed RNAPII chromatinimmunoprecipitation (ChIP) analysis after DBIRD knockdown. For a control, we also knocked down SIRT1 (Supplementary Fig. 5b ). Remarkably, although overall transcription of RAD50 and SLC36A4 is not affected (see Supplementary Fig. 7 ), depletion of DBC1 or ZIRD (but not SIRT1) markedly affected RNAPII transcription distinctively in regions encompassing affected exons (Fig. 4 and Supplementary  Fig. 11 ). Quantification of newly produced mRNA by bromo-UTP incorporation supported the idea that elongation rates were decreased in these regions (Supplementary Fig. 10 ). DBIRD depletion also affected RNAPII density at other genes whose splicing was exon-specifically affected, whereas little or no change in RNAPII density was observed at the unaffected b-actin control gene, even at exons that had an elevated DBIRD level ( Supplementary Figs 11 and 12 ; compare to Supplementary Fig. 8 ).
Our data support the idea that the DBIRD complex functions at the interface between core mRNP particles and RNAPII, affecting local transcript elongation rates and alternative splicing at a subset of (A 1 T)-rich exon-intron junctions ( Supplementary Fig. 13) . Notably, several studies have shown that the rate of RNAPII elongation affects the efficiency of splicing, with slow elongation favouring exon inclusion 1, 3 . Therefore, one possible explanation for our data is that the DBIRD complex acts as an elongation factor that facilitates transcript elongation across (A 1 T)-rich regions, and thereby affects alternative splicing of exons in these regions. It has also been suggested that exons in the nascent pre-mRNA become tethered to the elongating transcription complex 14, 15 . Given that DBIRD binds both mRNPs and RNAPII, it might affect such tethering, and thereby affect splicing.
DBC1 has been implicated in tumorigenesis as a potential tumour suppressor, regulating apoptosis and cell survival 16 . Whether the role of DBC1 in the DBIRD complex and alternative splicing affects tumorigenesis is an interesting possibility, particularly in light of the recent finding that genes encoding components of the splicing machinery are often mutated in myelodysplastic syndromes and related disorders 17 . ZIRD has not previously been characterized in human cells, but its mouse homologue, ZAN75, is highly expressed in neuronal tissues 18 , suggesting that regulation of the DBIRD complex might contribute to 
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tissue-specific splicing. Other proteins with homology to ZIRD and DBC1 exist in the human genome, raising the possibility that other DBIRD-like complexes are specific for other sets of genes or exons, or are involved in other transcription-related nuclear events.
METHODS SUMMARY
Open reading frames encoding hnRNP A1, DBC1 and ZIRD were cloned into pIRESpuro (Clontech) with a carboxy-terminal Flag tag. HEK293 cells were grown in Dulbecco's Modified Eagle Medium (DMEM) containing 10% FBS in 5% CO 2 at 37 uC. For proteomic analysis, nuclei were isolated from hnRNP A1-Flag cells. These were sonicated and treated with DNase I, and the sample was cleared by centrifugation and the supernatant was subjected to M2 agarose (Sigma) chromatography. Proteins were eluted with 33 Flag peptide and mass spectrometry was performed as has been described elsewhere 10 . DBIRD was purified by M2 agarose chromatography from nuclease-treated nuclear extract from cells expressing ZIRD-Flag. DBIRD was analysed by MonoQ, or size exclusion chromatography with or without an excess of RNAPII. Stealth short interfering RNAs (siRNAs) were double transfected in HEK293 cells using lipofectamine 2000 (Invitrogen). For microarray analysis, RNA was hybridized on Human Exon 1.0 ST arrays (Affymetrix) using standard techniques (bioinformatics analysis described in Methods). For assessment of exon abundance and transcript expression, quantitative RT-PCR was performed using primers against affected and unaffected exons. Primer details are given in Supplementary Table 2 . RNA immunoprecipitation and ChIP assays were performed as described 11, 19 . Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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Plasmids and antibodies. Open reading frames encoding human hnRNP A1, DBC1 and ZIRD (ZNF326) were cloned into pIRESpuro (Clontech) with a Flag tag at the C terminus. Antibodies used were rabbit anti-Flag, mouse anti-Flag M2 and mouse anti-hnRNP C (Sigma); mouse anti-pCTD mAb 4H8 (Millipore); rabbit anti-lamin B2 (Acris); rabbit anti-ZNF326 and mouse anti-hnRNP A1 (Santa Cruz Biotechnology); and rabbit anti-DBC1 and rabbit anti-SIRT1 (Bethyl Laboratories). Cell culture, stable-cell-line establishment and stealth siRNA transfection. HEK293 cells were grown in DMEM containing 10% FBS in 5% CO 2 at 37 uC.
To generate HEK293 stably expressing a Flag-tagged protein, cells were transfected with the relevant pIRESpuro construct and selected in 1 mg ml 21 puromycin (Sigma). Cells were maintained in selecting media for 3 weeks, and surviving cells were used for experiments after transgene expression was checked.
Stealth siRNAs were double transfected in HEK293 cells using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Protein and RNA expression was checked 48 h after the second transfection. Stealth siRNA anti-ZIRD RNAi sequences were: 59-CGGAGGUAGUUAUGGUGGUCGAUUU-39 (sense); 59AAAUCGACCACCAUAACUACCUCCG-39 (antisense). Stealth siRNA anti-DBC1 RNAi sequences were: 59-CCAUCUGUGACUUCCUAGAAC UCCA-39 (sense); 59-UGGAGUUCUAGGAAGUCACAGAUGG-39 (antisense). For stealth siRNA anti-SIRT1 we used validated stealth siRNA (Invitrogen; oligo ID VHS50609). For control siRNA we used Stealth siRNA negative control med GC (Invitrogen;12935-300). Immunopurification of native mRNPs. 10 8 cells stably expressing hnRNP A1-Flag were lysed with cytoplasmic lysis buffer (10 mM Tris HCl (pH 7.9), 340 mM sucrose, 3 mM CaCl 2 , 2 mM Mg(OAc) 2 , 0.1 mM EDTA, 1 mM dithiothreitol (DTT), 0.5% tergitol-type NP-40, protease inhibitors and 1 ml ml 21 RNasin Ribonuclease inhibitor (Promega)), and intact nuclei were pelleted by centrifugation at 3,500g for 15 min. Nuclei were washed with cytoplasmic lysis buffer without NP-40 and then resuspended in DNase I buffer (20 mM HEPES (pH 7.9), 10% glycerol, 1.5 mM MgCl2, 1 mM DTT, protease inhibitors and 1 ml ml 21 RNasin). After ten strokes in a Dounce homogenizer, nuclei were sonicated using Bioruptor (Diagenode) before DNase I (Sigma) was added to the buffer and incubated for 30 min at room temperature. Buffer was then adjusted to a final concentration of 250 mM KOAc and 1% Triton X-100. The sample was cleared by centrifugation at 20,000g for 30 min and the supernatant was collected. For negative control purification, the same extracts were prepared from the same amount of untagged cells.
The sample was then applied to M2 agarose beads (Sigma) and incubated for 4 h at 4 uC. After binding, beads were washed extensively with washing buffer (20 mM HEPES (pH 7.9), 250 mM KOAc, 1% Triton X-100, 10% glycerol, 3 mM EDTA, 1 mM DTT, protease inhibitors and 1 ml ml 21 RNasin Ribonuclease inhibitor) 10 . Finally, proteins were eluted by using Flag elution buffer (20 mM HEPES (pH 7.9), 100 mM KOAc, 3 mM EDTA, 1 mM DTT, 200 mg ml 21 33 Flag peptide, protease inhibitors and 1 ml ml 21 RNasin Ribonuclease inhibitor). Eluates were resolved by 4-12% bis-Tris-gradient SDS-PAGE and revealed by SYPRO Ruby staining (Invitrogen). Mass spectrometric analysis. Protein samples were reduced, alkylated and digested with trypsin, using the Janus liquid handling system (PerkinElmer). The digests were subsequently analysed by liquid chromatography tandem mass spectrometry on an LTQ Orbitrap XL mass spectrometer (ThermoScientific). The resulting data were searched against a protein database (UniProt KB) using the Mascot search engine programme (Matrix Science) 21 . All data were analysed manually. Purification of the DBC1-ZIRD complex. Nuclei from approximately 10 9 ZIRD-Flag cells were isolated, washed as above and then sonicated (Bioruptor, 30-s on-off cycles, max intensity for 15 min). Nucleic acids were digested by adding 10,000 units per ml Benzonase (Novagen) and 30 mg ml 21 RNase A (Sigma), and incubating at 4 uC for 1 h. The nuclear extract was then adjusted to a final concentration of 250 mM KOAc and the insoluble fraction was removed by centrifugation (20,000g for 30min). The supernatant was used for Flag-M2 chromatography. After extensive washes (60 column volumes of 20 mM HEPES-KOH (pH 7.9), 0.5% Triton X-100, 10% glycerol and 250 mM KOAc), bound proteins were eluted in the same buffer as above but containing 0.5 mg ml 21 33 Flag peptide (and 100 mM KOAc). The complex was then dialysed into buffer A (20 mM Tris-HCl (pH 7.9), 10% glycerol and 0.01% NP-40) containing 100 mM NaCl, before MonoQ PC 1.6/5 (GE Healthcare) or size exclusion (Superose 6 PC 3.2/30; GE Healthcare) chromatography. Proteins were eluted from MonoQ by a salt gradient from 0.1 to 1 M NaCl in buffer A. For size-exclusion chromatography, samples were loaded in buffer B (20 mM HEPES-KOH, 0.01% NP40, 10% glycerol and 250 mM KOAc) with or without pre-incubation on ice with a five-to tenfold molar excess of purified mammalian RNAPII, purified as described 22 . Fifty-micolitre fractions were collected, and sizes were estimated by running protein size markers (Biorad) in parallel. Microarray analysis. RNAs were extracted using RNeasy Kit (Qiagen), DNase-Itreated on the column, labelled and hybridized on Human Exon 1.0 ST arrays (Affymetrix) using standard techniques. Three independent experiments were performed and used as real triplicate for data analysis. We processed core-probe-level signals using robust multiarray average (RMA) implemented in APT (apt-1.10.0, Affymetrix) to generate quantile-normalized probe-set and gene-level signal estimates. Probe set to transcript cluster metagrouping was obtained from Affymetrix. We removed control probe sets from further analysis. For the gene-level analysis, genes displaying a coefficient of variance of less than 0.05 were assumed to be uninformative and were removed. We determined transcriptional effects (DBC1 versus control, ZIRD versus control and DBC1 versus ZIRD) by linear model, moderating the t-statistics by empirical Bayes shrinkage. We selected differential genes using a 0.05 P-value threshold using a nested F method. The analysis was carried out using the limma package from Bioconductor version 2.3 (ref. 23) .
To identify putative alternative splicing events we first filtered probe sets to reduce false positive events. We removed all probe sets that did not localize to unique loci in the genome (Affymetrix annotation). We removed all probe sets from transcripts identified as not expressed in a given condition, as it is not possible to determine alternative splicing events against an untranscribed background. We defined a transcript as not being expressed if less than half of its member probe sets had a detection P value (detection above background value (dabg)) of less than 0.05 across all replicates. We also removed probe sets displaying a dabg value of greater than 0.05 in all replicates in both the conditions being considered. Genes with less than three probe sets after filtering were also removed from the analysis. To identify pairwise alternative splicing events we fitted transcript-cluster-specific linear models to probe set signal estimates and tested for significant interactions between each probe set and gene-level signal estimates across pairwise conditions using a 0.01 P-value threshold and a nested F method. In cases in which multiple probe sets mapped to a single exon, only probe sets that had significant interactions were included in the results. Once again the analysis was carried out using the limma package from Bioconductor 23 .
Computational analysis of sequences around affected exons. To investigate sequence features that might explain the differential enrichment of certain exons after knockdown of ZIRD or DBC1, we selected a set of 505 exons that were 1.5-fold enriched in both the ZIRD and the DBC1 knockdowns and which were not the first or the last exon (to avoid including 59 and 39 untranslated regions in the following analyses). As a negative control set, we selected a further 3,877 exons that were unaffected after depletion of ZIRD and that were not the first or the last exon in the gene. We then prepared a positive and a negative sequence set for both the 59 and 39 splice sites. For the 59 splice site, the positive set contained the regions from 2200 nucleotides to 150 nucleotides around the 59 splice sites of the 505 enriched exons. The negative control set contained corresponding regions for the 3,877 unaffected exons. Similarly, the positive set for the 39 splice site contained the region from 250 nucleotides to 1200 nucleotides around the 39 splice sites of the 505 enriched exons, and the negative set contained the corresponding regions of the 3,877 unaffected exons.
The P values in Supplementary Fig. 9 were obtained in the following way. Suppose ab to be a dinucleotide and i a position around a splice site. We calculated the frequency P exp (i,ab) of ab that we would expect given the frequency of ab in the negative set, P neg (i,ab), and given the frequencies in the positive (P pos ) and negative (P neg ) sets of mononucleotide a at position i, and b at position i11, respectively:
ð Þ~P neg i,ab ð Þ P pos i,a ð ÞP pos iz1,b ð Þ P neg i,a ð ÞP neg iz1,b ð Þ
The P values for the observed number of dinucleotides ab at position i were calculated by approximating the binomial distribution with a normal distribution:
where N is the number of sequences in the set of affected exons, K is the number of observed dinucleotes ab at position i, Np is the expected number of dinucleotides at i, p 5P exp i,ab ð Þ, k is the summation value, and erfc is the complementary error function. Quantitative RT-PCR. RNAs were extracted using RNeasy Kit (Qiagen) and DNase-I-treated on the column, and 1 mg of total RNA was retro-transcribed using random primers and a first-strand complementary DNA synthesis kit (Fermentas). Quantitative RT-PCR was performed using SYBR Green detection. Specific primers against the alternatively spliced exon and unaffected exons were designed to assess exon abundance and transcript expression. Sequences are available on request.
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